Optellum is a commercial-stage lung health company providing Artificial Intelligence decision support software that assists physicians in early diagnosis and optimal treatment for their patients. We want every lung disease patient to be diagnosed and treated at the earliest possible stage, when chances of cure are the highest. Optellum’s roadmap extends beyond lung cancer diagnosis and treatment to other deadly diseases of the lungs, including interstitial lung disease and chronic obstructive pulmonary disease.
Northwestern Medicine Canning Thoracic Institute
Northwestern Medicine Canning Thoracic Institute is among the top-ranked for pulmonology and lung surgery.
Nordic Bioscience A/S
Nordic Bioscience is a Danish biomarker company headquartered in Herlev, Denmark. Nordic Bioscience is engaged in biomarker development using our unique neoepitope technology. We combine our expertise in biomarker development with preclinical and clinical research. This enables us to develop biomarkers that provide fast and objective decision-making for compound selection and development in clinical trials as well as provide value for patients in a diagnostic setting.
Noah Medical
Noah Medical operates with patients and physicians as our focus. We’re building cutting-edge medical technologies to enable providers to treat patients early and save lives while leaving minimal scars behind.
New Day Diagnostics
xxx | New Day Diagnostics (NDDx) is a precision diagnostics and bioresearch company expanding access to colorectal cancer screening and advancing clinical innovation. Our flagship is ColoHealth (FDA-approved), supported by a growing portfolio that includes ColoHealth Direct LDT—a lab-developed option built to simplify ordering, improve patient completion, and scale across clinical, employer, and telehealth channels. We focus on quality, compliance, and partnerships to deliver reliable results.
Metriport
Metriport transforms fragmented patient data into actionable clinical intelligence, delivering comprehensive medical summaries in minutes. Our open-source platform aggregates patient data from hundreds of thousands of sources—EHRs, ADTs, HIEs, Quest, Surescripts—with coverage for 300M+ individuals across the country. No more fax machines, phone tag, data gaps, or delays. Turn data chaos into data clarity. Enable your team with actionable insights at the point of care, automated workflows, care gap closures, & more. | Metriport transforms fragmented patient data into actionable clinical intelligence, delivering comprehensive medical summaries in minutes. Our open-source platform aggregates patient data from hundreds of thousands of sources—EHRs, ADTs, HIEs—with coverage for 300M+ individuals across the country. No more fax machines, phone tag, data gaps, or delays. Turn data chaos into data clarity. Enable your team with actionable insights at the point of care, automated workflows, care gap closures, & more.
MERIT
MERIT has provided image collection, centralized reading, and data management services for clinical trials since 2012. Through innovative and proven technologies, alongside our intuitive, seamless workflows, MERIT’s experienced staff bring more than a decade of clinical endpoint expertise, ensuring the success and integrity of your clinical trials. Our team has managed 100+ oncology studies across 20+ cancer types. MERIT values your partnership and will make your study a priority! Connect with us by email at oncology@meritcro.com or call (608) 509-7122. | MERIT provides reliable and attentive expertise for your clinical trial endpoint analysis. We specialize in respiratory studies, offering agile centralized spirometry expertise. MERIT has a proven track record providing endpoint expertise to 12 of the top 20 global pharma companies. We conduct studies across the globe, supporting sites in 63 countries. If you’re looking for a partner that will bring dedication and expertise to your clinical trial, consider MERIT.